Thailand scraps plan for 16-week dose gap on AstraZeneca vaccine

  • 4 months   ago
Thailand scraps plan for 16-week dose gap on AstraZeneca vaccine

Thailand has abandoned its plan for a 16-week gap between doses of the AstraZeneca (AZN.L) coronavirus vaccine and will opt for a shorter interval of 10 to 12 weeks instead, a senior health official said on Friday.

The government, which plans to use the AstraZeneca vaccine for most of its inoculations, had sought to reach more people faster by stretching the gap to 16 weeks, beyond the 12 weeks maximum approved by the European Medicines Agency.

 

A 16-week interval has not been tested in human trials.

But Sophon Mekthon, the public health minister's assistant, told Reuters Thailand's communicable disease committee wanted to revert to the previous interval, adding that it could still be extended in future if necessary.

Comments